As of 2025-04-23, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.16 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of BetterLife Pharma Inc is -275.39%.
Based on its market price of 0.09 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 275.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -0.16 - -0.16 | -0.16 | -275.39% |
DDM - Stable | (0.32) - (5.12) | (2.72) | -3122.6% |
DDM - Multi | (0.92) - (11.77) | (1.73) | -2018.9% |
Market Cap (mil) | 11.65 |
Beta | -0.42 |
Outstanding shares (mil) | 129.46 |
Enterprise Value (mil) | 12.49 |
Market risk premium | 5.10% |
Cost of Equity | 7.71% |
Cost of Debt | 5.00% |
WACC | 7.43% |